Evidence map›Paper›PMID 35540230›Full record

ArticleRSC advances2019

Dynamic Halbach array magnet integrated microfluidic system for the continuous-flow separation of rare tumor cells.

Mei Xue, An Xiang, Yanhai Guo, Li Wang, Rou Wang, Wenwen Wang, Gang Ji, Zifan Lu

Abstract read
In one paragraph

Article in RSC advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Mei XueCenter for Translational Medicine, The First Affiliated Hospital of Xi'an Jiaotong University Xi'an 710061 Shaanxi People's Republic of China.
An XiangDepartment of Biopharmaceutics, School of Pharmacy, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China luzfliuq@fmmu.edu.cn.
Yanhai GuoDepartment of Biopharmaceutics, School of Pharmacy, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China luzfliuq@fmmu.edu.cn.
Li WangDepartment of Biopharmaceutics, School of Pharmacy, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China luzfliuq@fmmu.edu.cn.
Rou WangDepartment of Biopharmaceutics, School of Pharmacy, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China luzfliuq@fmmu.edu.cn.
Wenwen WangDepartment of Biopharmaceutics, School of Pharmacy, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China luzfliuq@fmmu.edu.cn.
Gang JiXijing Hospital of Digestive Diseases, Xijing Hospital, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China.
Zifan LuDepartment of Biopharmaceutics, School of Pharmacy, Air Force Medical University (The Fourth Military Medical University) Xi'an 710032 Shaanxi People's Republic of China luzfliuq@fmmu.edu.cn.ORCID https://orcid.org/0000-0003-3816-3510

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Circulating tumor cells (CTCs), the most representative rare cells in peripheral blood, have received great attention due to their clinical utility in liquid biopsy. The downstream analysis of intact CTCs isolated from peripheral blood provides important clinical information for personalized medicine. However, current CTC isolation and detection methods have been challenged by their extreme rarity and heterogeneity. In this study, we developed a novel microfluidic system with a continuously moving Halbach array magnet (dHAMI microfluidic system) for negative isolation CTCs from whole blood, which aimed to capture non-target white blood cells (WBCs) and elute target CTCs. The dynamic and continuous movement of the Halbach array magnet generated a continuous magnetic force acting on the magnetic bead-labelled WBCs in the continuous-flow fluid to negatively exclude the WBCs from the CTCs. Furthermore, the continuously moving magnetic field effectively eliminated the effect of magnetic bead aggregation on the fluid flow to realize the continuous-flow separation of the CTCs without a sample loading volume limitation. The experimental procedure for CTC negative isolation using the dHAMI microfluidic system could be completed within 40 min. Under the optimized experimental conditions of the dHAMI microfluidic system, including the flow rate and concentration of the immunomagnetic bead, the average CTC capture rate over a range of spiked cell numbers (50-1000 cancer cells per mL) was up to 91.6% at a flow rate of 100 μL min

Identifiers

PMID35540230
PMCPMC9075830

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.